Navigation Links
HHS Announces New International Programs to Enhance Drug and Food Safety
Date:7/9/2008

Joint Inspections with European Union and Australian Regulators; Third-Party Certification Program Are Latest Steps toward Implementing New Import Strategy

WASHINGTON, July 9 /PRNewswire-USNewswire/ -- U.S. Health and Human Services (HHS) Secretary Mike Leavitt today announced two groundbreaking programs designed to enhance the safety of food and medical products exported to the United States.

"These programs will significantly increase our collaboration with international and private sector partners to enhance the safety of imported food and medical products," Secretary Leavitt said. "Working together, we intend to offer expedited access to those products shown to meet our standards and to focus more of our resources on those products that present higher risks."

Secretary Leavitt made the announcement in a speech to hundreds of industry leaders at an Import Safety Summit in Washington. He described the twin initiatives as the latest steps in a fundamental, government-wide shift to implement the Interagency Import Safety Action Plan finalized in November 2007. Historically, U.S. authorities have primarily relied on intervening at the border to intercept unsafe goods. The new strategy calls for actively working with trading partners to help ensure they build quality into every step of a product's life cycle, targeting critical points where risk is greatest, and focusing attention and resources on these areas.

The first initiative is a pilot project the HHS Food and Drug Administration (FDA) is undertaking with its counterparts in the European Union and Australia to jointly plan, allocate for and conduct inspections of drug-manufacturing facilities. The project will initially focus on makers of active pharmaceutical ingredients. If successful, this program could expand to include other types of manufacturing facilities. The novel collaboration will allow HHS/FDA to more fully take advantage of information gathered by trusted inspection and regulatory systems in other countries.

The second initiative is a third-party certification pilot program involving aquacultured (farm-raised) shrimp. HHS/FDA is seeking the participation of certification bodies that currently certify foreign processors of aquacultured shrimp for compliance with the FDA's seafood regulations. The project is designed to help HHS/FDA learn how to evaluate third-party certification programs and implement them in the field -- a key part of leveraging the additional resources of the private sector and other regulators.

Additional information about import safety initiatives is available at http://www.importsafety.gov.

Note: All HHS press releases, fact sheets and other press materials are available at http://www.hhs.gov/news.


'/>"/>
SOURCE U.S. Department of Health and Human Services
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. TUMS Announces Nationwide Search for Grand Marshal at TUMS QuikPak 500
2. Nyer Medical Group, Inc. Announces Sale of Companys Florida Medical-Surgical Division; Pharmacy Division Awarded Two-Year Preferred Supplier Contract
3. Licensed Rx Announces Latest Customer Savings Scheme
4. Mariners Inn Announces New Executive Leadership
5. Summit Doppler Announces the Seated ABI for the Diagnosis of Peripheral Arterial Disease
6. Global Med Technologies(R) Announces U.S. Release of Proven Tissue and Cellular Therapy Product
7. Monogram Announces Commercial Availability of the HERmark(TM) Breast Cancer Assay
8. The Center for Professional Innovation and Education (CfPIE) Announces the First True Certification Program for Document Management Professionals in the Life Sciences
9. The Center for Professional Innovation and Education (CfPIE) Announces a New Global Regulatory Certification Track
10. GRAS Proudly Announces Photometrica Version 2.0. Hailed as a Brilliant Solution for More Productive Astronomical Research by Those Engaged in Photometry Using the Global-Rent-a-scope Telescope Systems
11. NHP Announces Second Quarter Earnings Release Date and Conference Call/Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... ... May 02, 2016 , ... Dr. Rassouli, dentist in ... cognitive decline. According to the research, which was published in the “Journal of the ... decline, and about 5.4 million Americans have Alzheimer’s disease. The study found that dental ...
(Date:5/2/2016)... Boston, MA (PRWEB) , ... May 02, 2016 , ... ... and tips when trying to conceive. , “If you are ready to ... Dr. Mache Seibel. “My book, HealthChequesTM: Journal Babies is your Personal Conception & ...
(Date:5/2/2016)... ... ... Kulbersh of Carolina Facial Plastics isn’t surprised that Charlotte, NC, the city where he and ... Cities with the Highest Plastic Rates .” The other cities that made the list ... a survey by RealSelf and combining that data with the number of board-certified ...
(Date:5/2/2016)... Beach, FL (PRWEB) , ... May 02, 2016 , ... ... to great pain and suffering. With no cure, most patients must deal with prescription ... a free coupon card, allowing up to 75% savings at the pharmacy on many ...
(Date:5/2/2016)... ... May 02, 2016 , ... ... which includes amniotic fluid/“stem cells” and Platelet Rich Plasma (PRP) injections. “These are ... said Dr. James Baranski, D.C., of Advanced Spine & Sport Medical. “We are ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... -- The blood testing market in China ... and The Freedonia Group in a recent report.  The ... healthcare research firm said that China ... and in improving testing at the provincial level.   The ... Blood Testing Market in China , which utilized ...
(Date:4/28/2016)... 2016   Acsis , a leading provider of ... market research and advisory firm IDC has named it ... Worldwide Pharmaceutical Track and Trace Software 2016 Vendor Assessment ... assessment of the capabilities and business strategies of 10 ... Logo - http://photos.prnewswire.com/prnh/20160427/360791LOGO ...
(Date:4/27/2016)... 2016 Im ... Zürich gab Strekin AG den Start einer ... Erhaltung des Resthörvermögens von Patienten, denen ein ... umfassende Phase-II-Doppelblindstudie mit Placebo-Kontrollgruppe werden momentan Patienten ... während der Operation direkt ins Mittelohr verabreicht. ...
Breaking Medicine Technology: